A one-year license of FDA-cleared Icometrix Icobrain software is sought to provide AI-driven neuroimaging analysis for the diagnosis and assessment of brain disorders. The software will enable attending physicians to examine structural neuroimages acquired using MRI or CT equipment as part of their standard brain scan protocol.

Icometrix Icobrain software functions as a CE-marked medical device and aids physicians by providing volumetric measurements that are compared to an age- and sex-matched reference database. This comparative analysis supports the clinical assessment of various neurological conditions, including Multiple Sclerosis, Alzheimer's disease, dementia, epilepsy, traumatic brain injury, and stroke.

Vendors must supply the software as a continuity solution, ensuring seamless integration into existing workflows to enhance the accuracy and efficiency of neurological diagnoses.